Company · CIK 0001279704 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Cellectar Biosciences, Inc. · CLRB
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 8, 2026 AForm 4/A → | Jul 10, 9:00 pm EDT | Stefan LorenOther | 15,000 | — | — | 15,000 | — | |
| Jul 8, 2026 AForm 4 → | Jul 8, 9:00 pm EDT | Stefan LorenOther | 15,000 | — | — | 15,000 | — | amended |
| Jul 7, 2026 AForm 4 → | Jul 8, 9:13 pm EDT | Chad J KoleanCFO | 92,000 | — | — | 92,000 | — | |
| Jul 7, 2026 AForm 4 → | Jul 8, 9:10 pm EDT | Frederick W DriscollDirector | 25,000 | — | — | 25,000 | — | |
| Jul 7, 2026 AForm 4 → | Jul 8, 9:09 pm EDT | Asher Chanan-KhanDirector | 25,000 | — | — | 25,000 | — | |
| Jul 7, 2026 AForm 4 → | Jul 8, 9:07 pm EDT | James V CarusoPresident & CEO, Director | 250,000 | — | — | 250,000 | — | |
| Jul 7, 2026 AForm 4 → | Jul 8, 9:06 pm EDT | Andrew GuDirector | 25,000 | — | — | 25,000 | — | |
| Jul 7, 2026 AForm 4 → | Jul 8, 9:05 pm EDT | Jarrod LongcorChief Operating Officer | 118,000 | — | — | 118,000 | — | |
| Jul 7, 2026 AForm 4 → | Jul 8, 9:04 pm EDT | Douglas J SwirskyDirector | 37,500 | — | — | 37,500 | — | |
| Jul 7, 2026 AForm 4 → | Jul 8, 9:02 pm EDT | John NeisDirector | 25,000 | — | — | 25,000 | — |